Immediate respiratory management of the preterm infant

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Biomedical Science

Background:

• Premature infants exhibit underdeveloped lungs with morphological and biochemical abnormalities.
• Respiratory Distress Syndrome (RDS) is a primary cause of illness and death in premature neonates.
• Current treatments like surfactant replacement therapy and CPAP show benefits but their optimal use remains debated.

Purpose of the Study:

• To review the underlying pathophysiology of Respiratory Distress Syndrome (RDS).
• To evaluate the evidence supporting surfactant replacement therapy for RDS.
• To assess the evidence for continuous positive airway pressure (CPAP) in managing RDS.

Main Methods:

• Literature review of existing studies on RDS pathophysiology.
• Analysis of clinical trial data for surfactant replacement therapy.
• Examination of research on the efficacy of CPAP in premature infants.

Main Results:

• Detailed explanation of lung development abnormalities in preterm infants.
• Summary of surfactant therapy's role in RDS management.
• Overview of CPAP's effectiveness and application in neonatal care.

Conclusions:

• Understanding RDS pathophysiology is crucial for effective treatment.
• Evidence supports both surfactant therapy and CPAP, but optimal combination and timing require further research.
• This review provides a comprehensive overview to guide clinical practice in RDS management.